With three shots on goal over weeks ahead, and FDA approving submissions for EUA, what is not to like!  

1) What do you think the chances of approval are for a Covid-19 Antibody test that delivers greater than 99% accuracy in 24 hours? 
2) RALI-dx Covid-19 Severity/Triage test that delivers results of 5 key biomarkers in under an hour.  
3) RALI-fast measures IL-6, the most informative cytokine biomarker predicting adverse path (cytokine storm) probability in under 15 minutes.  
 
Each Approval on its own is worth more than SQI's present value.    
 
This company will be worth a quarter of a billion (USD) by spring.  
 
Science Quality Innovation is about to be discovered.  
 
Stay Tuned